
22.52 Delayed Data As of May 26 | ![]() Today’s Change | 14.89 Today|||52-Week Range 30.22 | -2.93% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Collegium Pharmaceutical Inc have a median target of 35.00, with a high estimate of 40.00 and a low estimate of 30.00. The median estimate represents a +55.42% increase from the last price of 22.52.
The current consensus among 7 polled investment analysts is to Buy stock in Collegium Pharmaceutical Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.